Lang C C, Stein C M, He H B, Belas F J, Blair I A, Wood M, Wood A J
Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tenn 37232-6602, USA.
Hypertension. 1997 Aug;30(2 Pt 1):157-62. doi: 10.1161/01.hyp.30.2.157.
Enhanced sympathetic reactivity may predispose blacks to the development of hypertension and may occur because of increased sympathetic stimulation and/or attenuated sympathoinhibition. A potential site for such attenuated sympathetic inhibition may be at the level of central alpha2-adrenergic receptors, which play an important role in the feedback inhibition of norepinephrine release. We used cumulative doses (1, 2, and 3 microg/kg I.V.) of the centrally acting alpha2-adrenergic agonist clonidine to measure the sensitivity of alpha2-adrenoceptor-mediated sympathoinhibition and the resultant hypotensive response in 8 normotensive blacks and 10 normotensive whites. Sympathetic activity was determined by radioisotope dilution methodology. Basal norepinephrine spillover was similar in blacks (0.80+/-0.14 microg/min) and whites (0.73+/-0.19 microg/min, P=NS) and after clonidine decreased significantly in both blacks (0.21+/-0.07 microg/min, P<.0001) and whites (0.24+/-0.06 microg/min, P<.0001), with no difference between the groups (P=NS). Despite this similar degree of sympathoinhibition, the hypotensive response to clonidine was markedly blunted in blacks, such that mean arterial pressure decreased by only 10% in blacks but by 21% in whites (P<.0001). The smaller blood pressure decrement after clonidine in normotensive blacks, in the face of an equal degree of sympathoinhibition, suggests that even when sympathetic tone is decreased to the same level in blacks and whites, normotensive blacks have less reduction in blood pressure than whites, implying that nonadrenergic mechanisms contribute more to blood pressure maintenance in blacks than whites. Whether a similar interethnic difference in response to sympathoinhibition occurs in hypertensive patients is as yet unknown.
增强的交感神经反应性可能使黑人更易患高血压,其发生可能是由于交感神经刺激增加和/或交感神经抑制减弱。这种交感神经抑制减弱的一个潜在部位可能是中枢α2-肾上腺素能受体水平,该受体在去甲肾上腺素释放的反馈抑制中起重要作用。我们使用中枢作用的α2-肾上腺素能激动剂可乐定的累积剂量(1、2和3微克/千克静脉注射)来测量α2-肾上腺素能受体介导的交感神经抑制的敏感性以及8名血压正常的黑人和10名血压正常的白人中由此产生的降压反应。通过放射性同位素稀释法测定交感神经活动。黑人(0.80±0.14微克/分钟)和白人(0.73±0.19微克/分钟,P=无显著性差异)的基础去甲肾上腺素溢出相似,可乐定给药后,黑人和白人的基础去甲肾上腺素溢出均显著降低(黑人:0.21±0.07微克/分钟,P<0.0001;白人:0.24±0.06微克/分钟,P<0.0001),两组之间无差异(P=无显著性差异)。尽管交感神经抑制程度相似,但黑人对可乐定的降压反应明显减弱,以至于黑人的平均动脉压仅下降10%,而白人下降21%(P<0.0001)。在血压正常的黑人中,面对同等程度的交感神经抑制,可乐定给药后血压下降幅度较小,这表明即使黑人和白人的交感神经张力降低到相同水平,血压正常的黑人血压下降幅度也小于白人,这意味着非肾上腺素能机制在黑人血压维持中比在白人中起更大作用。高血压患者对交感神经抑制的反应是否存在类似的种族间差异尚不清楚。